Zacytuj

Single nucleotide polymorphism information and Hardy-Weinberg p values in the study population.

SNP Gene/ Closest Gene Chromosomal Position Location Allele Change Amino Acid Change HWE p Value
rs10783050 EEF1A1P11-RPL7P9 1:96571527 intergenic T>C 0.932
rs1143623 IL1B 2:112838252 intergenic C>G 0.309
rs13266634 SLC30A8 8:117172544 missense C>A/T Arg325Trp 0.532
rs13376631 FMO1 1:171266603 intron A>G 0.903
rs1801282 PPARG 3:12351626 missense C>G Pro12Ala monomorphic
rs249429 PRKAA1 5:40782137 intron C>T 0.299
rs2815752 NEGR1 1:72346757 intergenic G>A 0.636
rs316009 SLC22A2 6:160254732 intron C>T/G 0.595
rs316019 SLC22A2 6:160249250 missense C>A Ala270Ser 0.808
rs391300 SRR 17:2312964 intron C>T 0.739
rs461473 SLC22A1 6:160122530 intron G>A 0.898
rs4810083 PCK1 20:57545215 intergenic C>T 0.145
rs578427 6:91702432 intergenic T>C 0.909
rs622342 SLC22A1 6:160151834 intron A>C 0.218
rs6265 BDNF; BDNF-AS 11:27658369 missense C>T Val66Met monomorphic
rs819 2675 SLC2A2 3:171007094 intron C>T 0.674

Genotype and allele frequencies of 13 single nucleotide polymorphism(s) demonstrating no significant association to type 2 diabetes mellitus treatment response.

SNP Genotype/ Allele Control n (%) Uncontrolled n (%) OR (95% CI) p Values
rs10783050 TT 52 (98.1) 86 (98.9) reference
TC 1 (1.9) 0 (0.0) 0.20 (0.01-5.06) 0.331
T 105 (99.1) 172 (98.9) reference
C 1 (0.9) 0 (0.0) 0.20 (0.01-5.05) 0.332
rs1143623 CC 48 (90.6) 74 (85.1) reference
CG 5 (9.4) 11 (12.6) 1.43 (0.47-4.36) 0.533
C 96 (90.6) 159 (91.4) reference
G 10 (9.4) 11 (6.3) 0.66 (0.27-1.62) 0.369
rs13266634 CC 50 (94.3) 78 (89.7) reference
CT 3 (5.7) 8 (9.2) 1.71 (0.43-6.75) 0.444
100 (94.3) 164 (94.3) reference
6 (5.7) 8 (4.6) 0.81 (0.27-2.41) 0.709
rs13376631 AA 16 (30.2) 22 (25.3) reference
GG 11 (20.8) 17 (19.5) 1.12 (0.42-3.04) 0.818
AG 25 (13.3) 37 (42.5) 1.08 (0.47-2.44) 0.860
57 (53.8) 81 (46.6) reference
47 (44.3) 71 (40.8) 1.06 (0.64-1.75) 0.811
rs1801282 CC 53 (100.0) 86 (98.9) monomorphic monomorphic
C 106 (100.0) 172 (98.9)
rs249429 TT 28 (52.8) 40 (46.0) reference
CC 3 (5.7) 6 (6.9) 1.40 (0.32-6.07) 0.650
CT 22 (41.5) 40 (46.0) 1.27 (0.6258-2.5885) 0.510
T 78 (73.6) 120 (69.0) reference
C 28 (26.4) 52 (29.9) 1.21 (0.70-2.07) 0.500
rs2815752 GG 18 34.0) 22 (25.3) reference
AA 13 (24.5) 20 (23.0) 1.26 (0.49-3.21) 0.630
GA 22 (41.5) 43 (49.4) 1.60 (0.71-3.59) 0.254
58 (54.7) 87 (50.0) reference
48 (45.2) 83 (47.7) 1.15 (0.71-3.59) 0.567
rs34834489 GG 46 (86.7) 80 (92.0) reference
GA 6 (11.3) 6 (6.9) 0.58 (0.18-1.89) 0.361
98 (92.5) 166 (95.4) reference
6 (5.7) 6 (3.4) 0.59 (0.19-1.88) 0.373
rs391300 CC 9 (17.0) 17 (19.5) reference
TT 18 (34.0) 24 (27.6) 0.71 (0.26-1.94) 0.500
CT 26 (49.1) 44 (50.6) 0.90 (0.35-02.30) 0.819
44 (41.5) 78 (44.8) reference
62 (58.5) 92 (52.9) 0.84 (0.51-1.37) 0.477
rs461473 GG 52 (98.1) 84 (96.6) reference
GA 1 (1.9) 2 (2.3) 1.24 (0.11-14.00) 0.863
105 (99.1) 170 (97.7) reference
1 (0.9) 2 (1.1) 1.24 (0.11-13.99) 0.864
rs622342 AA 33 (62.3) 48 (55.2) reference
CC 3 (5.7) 12 (13.8) 4.13 (0.87-19.65) 0.075
CA 18 (34.0) 26 (29.9) 0.99 (0.472.10) 0.985
84 (79.2) 122 (70.1) reference
22 (20.8) 50 (28.7) 1.56 (0.88-2.78) 0.113
rs6265 CC 53 (100.0) 86 (98.9) monomorphic monomorphic
C 106 (100.0) 172 (98.9)
rs8192675 CC 42 (79.2) 58 (66.7) reference
TT 1 (1.9) 3 (3.4) 2.17 (0.22-21.62) 0.508
CT 9 (17.0) 25 (28.7) 2.01 (0.85-4.75) 0.111
93 (87.7) 141 (81.0) reference
11 (10.4) 31 (17.8 1.86 (0.89-3.88) 0.099

Genotype and allele frequencies of four single nucleotide polymorphism(s) demonstrating no significant association to type 2 diabetes mellitus treatment response.

Unadjusted Adjusted
SNP Genotype/ Allele Controlled n (%) Uncontrolled n (%) OR (95% CI) p Values OR (95% CI) p Values Bonferonni Corrected p Values
rs316009 CC 45 (84.9) 83 (95.4) reference reference
CT 8 (15.1) 3 (0.03) 0.20 (0.05-0.81) 0.023 0.31 (0.05-0.190) 0.204
98 (92.5) 169 (97.1) reference reference
8 (0.08) 3 (0.02) 0.22 (0.06-0.84) 0.027 0.85 (0.01-0.93) 0.044 0.088
rs316019 CC 41 (77.4) 77 (88.5) reference reference
AA 1 (0.02) 0 (0.0) 0.18 (0.01-4.48) 0.295
CA 11 (20.8) 8 (0.09) 0.39 (0.14-1.04) 0.059
C 93 (87.7) 162 (93.1) reference reference
A 13 (12.3) 8 (0.05) 0.35 (0.14-0.8) 0.026 0.72 (0.21-2.44) 0.593
rs4810083 CC 16 (30.2) 33 (37.9) reference reference
TT 10 (18.9) 32 (36.9) 1.55 (0.61-3.92) 0.353 1.24 (0.42-3.60) 0.698
CT 27 (35.7) 21 (43.1) 0.38 (0.17-0.86) 0.021 2.80 (1.01-7.79) 0.049 0.098
59 (55.7) 75 (43.1) reference reference
47 (44.3) 97 (55.7) 1.62 (1.00-2.64) 0.051 0.81 (0.48-1.36) 0.423
rs578427 TT 10 (18.9) 15 (17.2) reference reference
CC 4 (7.5) 28 (32.2) 4.67 (1.25-17.44) 0.022 1.80 (0.58-5.64) 0.312
CT 39 (73.6) 43 (49.4) 0.74 (0.30-1.83) 0.507 1.70 (0.45-2.55) 0.884
T 47 (44.3) 73 (42.0) reference reference
C 59 (55.7) 99 (56.9) 1.08 (0.66-1.76) 0.765 1.31 (0.78-2.22) 0.308

Clinical and biochemical demographics of the study population.

Parameters Controlled (n = 53) Uncontrolled (n = 87) p Value
Sex (F; M) F: 36; M: 14 F: 57; M: 30
Age (years) 60.7 ± 11.0 58.3 ± 11.4 0.470
Weight (kg) 85.8 ± 19.5 85.4 ± 19.1 0.833
Height (cm) 162.1 ± 7.8 163.1 ± 7.7 0.487
Body mass index 31.9 ± 8.4 30.4 ± 10.7 0.304
Hb A1c (%):
baseline 7.6 ± 2.0 11.0 ± 2.9 <0.001
12 months 6.7 ± 1.2 11.5 ± 2.9 <0.001
Random blood sugar (%) 9.4 ± 3.9 14.5 ± 6.6 <0.001
Systolic blood pressure (mmHg) 147.0 ± 24.0 153.5 ± 23.9 0.130
Diastolic blood pressure (mmHg) 83.9 ± 15.5 90.3 ± 13.7 0.018
Total cholesterol (mmol/L) 4.4 ± 1.1 5.0 ± 1.1 0.001
High-density lipoprotein (mmol/L) 1.2 ± 0.4 1.2 ± 0.4 0.672
Low-density lipoprotein (mmol/L) 2.3 ± 0.9 2.8 ± 0.9 0.007
Triglycerides (mmol/L) 2.0 ± 1.2 2.3 ± 1.1 0.215
Creatinine (g/mol) 157.7 ± 383.1 79.3 ± 29.5 0.317
Glomerular filtration rate (mL/min/1.73 m2 41.7 ± 21.5 52.6 ± 25.0 0.313
eISSN:
1311-0160
Język:
Angielski
Częstotliwość wydawania:
2 razy w roku
Dziedziny czasopisma:
Medicine, Basic Medical Science, other